In addition, mosaic disorders with excess FGF23, such as fibrous dysplasia, McCune-Albright syndrome, and cutaneous skeletal hypophosphatemia syndrome, will also show suppressed FGF23 expression in nondysplastic bone. This evidence concerns the gene FGF23 and fibrous dysplasia.